Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Rocket Pharmaceuticals (RCKT)  
$22.91 0.56 (2.51%) as of 4:30 Tue 6/11


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 92,610,000
Market Cap: 2.12(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $15.07 - $31.94
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Rocket Pharmaceuticals is a clinical-stage, multi-platform biotechnology company focused on the development of gene therapies for rare and devastating pediatric diseases. Co. has three clinical-stage ex vivo lentiviral vector. These include programs for Fanconi Anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells, Leukocyte Adhesion Deficiency-I, a genetic disorder that causes the immune system to malfunction, and Pyruvate Kinase Deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,355,932
Total Buy Value $0 $0 $0 $19,999,997
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 385,818 434,774 477,485 503,595
Total Sell Value $10,507,258 $11,964,318 $12,853,114 $13,363,000
Total People Sold 7 7 7 8
Total Sell Transactions 10 17 25 33
End Date 2024-03-14 2023-12-12 2023-06-13 2022-06-13

   
Records found: 142
  Page 4 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Schwartz Jonathan David See Remarks   •       •      –    2022-04-01 4/A AS $15.86 $724,589 D/D (45,000) 89,529     -
   Schwartz Jonathan David See Remarks   •       •      –    2022-03-31 4/A AS $15.90 $724,500 D/D (45,000) 134,529     -
   Schwartz Jonathan David See Remarks   •       •      –    2022-03-30 4 AS $15.94 $738,652 D/D (45,000) 179,529 2%     
   Shah Gaurav CEO   •       •      –    2022-02-14 4 A $0.00 $0 D/D 23,940 670,074     -
   Patel Kinnari See Remarks   •       •      –    2022-02-14 4 A $0.00 $0 D/D 11,970 313,794     -
   Militello John See Remarks   •       •      –    2022-02-14 4 A $0.00 $0 D/D 2,903 24,420     -
   Shah Gaurav CEO   •       •      –    2022-02-07 4 B $17.34 $381,513 D/D 22,000 517,639 0.01 -44%     
   Yalamanchi Naveen Director   –       •       •   2021-08-27 4 A $32.48 $26,390,520 I/I 812,516 16,272,635     -
   Makker Gotham   •       •      –    2021-07-27 4 GD $0.00 $0 I/I 621,500 674,901     -
   Makker Gotham   •       •      –    2021-06-17 4 S $47.13 $18,850 I/I (400) 1,296,401 33%     
   Makker Gotham   •       •      –    2021-06-16 4 S $46.85 $1,624,843 I/I (34,685) 1,296,801 37%     
   Yalamanchi Naveen Director   –       •      –    2021-05-11 4 S $40.03 $29,023,490 I/I (725,000) 15,460,119 23%     
   Shah Gaurav CEO   •       •      –    2021-04-01 4 D $45.21 $1,032,554 D/D (22,266) 495,639     -
   Shah Gaurav CEO   •       •      –    2021-03-31 4 D $45.94 $344,235 D/D (7,493) 517,905     -
   Shah Gaurav CEO   •       •      –    2021-03-31 4 D $44.24 $3,887,647 D/D (87,353) 525,398     -
   Shah Gaurav CEO   •       •      –    2021-03-31 4 OE $1.69 $128,237 D/D 75,880 612,751     -
   Shah Gaurav CEO   •       •      –    2021-03-30 4 D $41.80 $3,720,492 D/D (85,888) 536,871     -
   Yalamanchi Naveen Director   –       •      –    2021-03-24 4 D $0.00 $0 I/I (1,344,925) 16,185,119     -
   Patel Kinnari Chief Operating Officer   •       •      –    2021-03-24 4 OE $1.21 $131,979 D/D 93,962 188,939     -
   Schwartz Jonathan David Chief Medical Officer   •       •      –    2021-02-01 4 OE $1.21 $277,166 D/D 224,529 224,529     -
   Patel Kinnari Chief Operating Officer   •       •      –    2020-12-28 4 AS $56.51 $950,745 D/D (16,761) 94,977 -22%     
   Yalamanchi Naveen Director   –       •      –    2020-12-10 4 B $56.00 $13,872,320 I/I 247,720 17,530,044 2.1 -25%     
   Shah Gaurav President & CEO   •       •      –    2020-03-24 4 D $13.78 $449,848 D/D (32,645) 1,028,997     -
   Shah Gaurav President & CEO   •       •      –    2020-03-24 4 OE $0.43 $39,098 D/D 90,925 1,061,642     -
   Patel Kinnari Chief Operating Officer   •       •      –    2020-03-18 4 B $9.50 $9,500 I/I 1,000 6,675 0.01 152%     
  142 Records found
  1  2  3  4  5  6   
  Page 4 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us